Skip to content

Budesonide EP Impurity B

Budesonide EP Impurity B

Product Description
CAT No.
ALN-B022003
CAS No.
1040085-98-0
Mol. F.
C23H30O6
Mol. Wt.
402.5
Stock
Please Inquire
Chemical Name : 16α,17-[(1RS)-Ethylidenebis(oxy)]-11β,21-dihydroxypregna-1,4-diene-3,20-dione (as per EP & USP)
Smiles : C[C@@]12[C@@]3(C(CO)=O)[C@@](OC(O3)C)([H])C[C@@]1([H])[C@]4([H])CCC5=CC(C=C[C@]5(C)[C@@]4([H])[C@@H](O)C2)=O
Inchi : InChI=1S/C21H28O6/c1-19-6-5-12(23)7-11(19)3-4-13-14-8-16(25)21(27,17(26)10-22)20(14,2)9-15(24)18(13)19/h5-7,13-16,18,22,24-25,27H,3-4,8-10H2,1-2H3/t13-,14-,15-,16+,18+,19-,20-,21-/m0/s1
Synonym : Budesonide acetaldehyde acetal (epimers) (USP)

A validated stability indicating UHPLC method for the determination of anti-inflammatory corticosteroid budesonide epimers

By Vaddi, Lakshmi; Purushothaman, Vijayanthimala; Gowda, NagarajnFrom Journal of Pharmaceutical Sciences and Research (2020), 12(6), 848-852

Analytical method development and validation of formoterol fumarate and budesonide in pressurized meter dose inhaler form by using RP-HPLC

By Raghu, P. S. – From European Journal of Biomedical and Pharmaceutical Sciences (2018), 5(6), 1-6

Isolation and characterization of photodegradation impurity in budesonide drug product using LC-MS and NMR spectroscopy

By Bhutnar, Arun; Khapare, Sachin; Desai, Anita; Dsouza, Smitha – From American Journal of Analytical Chemistry (2017), 8(7), 449-461

Request For Quotation